Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
CRH
CRH
|
+$1.93B |
| 2 |
Texas Instruments
TXN
|
+$1.78B |
| 3 |
NVIDIA
NVDA
|
+$1.66B |
| 4 |
Starbucks
SBUX
|
+$1.15B |
| 5 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$974M |
Top Sells
| 1 |
Apple
AAPL
|
+$3.13B |
| 2 |
Microsoft
MSFT
|
+$1.38B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.32B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.13B |
| 5 |
Procter & Gamble
PG
|
+$923M |
Sector Composition
| 1 | Technology | 33.53% |
| 2 | Consumer Discretionary | 10.88% |
| 3 | Financials | 10.79% |
| 4 | Communication Services | 9.25% |
| 5 | Healthcare | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BOLD
3401
Boundless Bio
BOLD
$26M
| $68K | ﹤0.01% |
17,476
+2,476
| +17% | +$9.63K |
|
3402
Aquestive Therapeutics
AQST
$590M
| $67K | ﹤0.01% |
+25,770
| New | +$67K |
|
|
PINE
3403
Alpine Income Property Trust
PINE
$217M
| $67K | ﹤0.01% |
4,292
-4,516
| -51% | -$70.5K |
|
3404
Quantum-Si Incorporated
QSI
$227M
| $67K | ﹤0.01% |
63,388
-37,967
| -37% | -$40.1K |
|
3405
Sprott Uranium Miners ETF
URNM
$1.76B
| $67K | ﹤0.01% |
1,368
-11,476
| -89% | -$562K |
|
3406
Vanguard FTSE Europe ETF
VGK
$26.9B
| $67K | ﹤0.01% |
1,000
-273,200
| -100% | -$18.3M |
|
3407
VistaGen Therapeutics
VTGN
$110M
| $67K | ﹤0.01% |
19,261
-3,816
| -17% | -$13.3K |
|
|
TE
3408
T1 Energy Inc.
TE
$292M
| $67K | ﹤0.01% |
39,243
-140,757
| -78% | -$240K |
|
|
BLUE
3409
DELISTED
bluebird bio
BLUE
| $66K | ﹤0.01% |
3,373
-3,343
| -50% | -$65.4K |
|
3410
Incannex Healthcare
IXHL
$49.7M
| $66K | ﹤0.01% |
22,502
+22,500
| +1,125,000% | +$66K |
|
3411
Lantronix
LTRX
$184M
| $66K | ﹤0.01% |
18,551
-35,872
| -66% | -$128K |
|
3412
Lexicon Pharmaceuticals
LXRX
$392M
| $66K | ﹤0.01% |
39,437
-25,182
| -39% | -$42.1K |
|
3413
Vanguard Value ETF
VTV
$144B
| $66K | ﹤0.01% |
412
| – | – |
|
3414
Weyco Group
WEYS
$285M
| $66K | ﹤0.01% |
2,200
-2,018
| -48% | -$60.5K |
|
3415
Xoma
XOMA
$442M
| $66K | ﹤0.01% |
2,809
-2,352
| -46% | -$55.3K |
|
|
ITI
3416
DELISTED
Iteris, Inc.
ITI
| $66K | ﹤0.01% |
15,231
-15,292
| -50% | -$66.3K |
|
|
BRT
3417
BRT Apartments
BRT
$290M
| $65K | ﹤0.01% |
3,717
-4,202
| -53% | -$73.5K |
|
3418
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.32B
| $65K | ﹤0.01% |
2,733
| – | – |
|
3419
iHeartMedia
IHRT
$323M
| $65K | ﹤0.01% |
59,026
-44,444
| -43% | -$48.9K |
|
3420
Norwood Financial Corp
NWFL
$245M
| $65K | ﹤0.01% |
2,572
-2,494
| -49% | -$63K |
|
3421
Omega Flex
OFLX
$341M
| $65K | ﹤0.01% |
1,275
-1,808
| -59% | -$92.2K |
|
3422
iShares MSCI India Small-Cap ETF
SMIN
$927M
| $65K | ﹤0.01% |
800
| – | – |
|
3423
AlTi Global
ALTI
$399M
| $64K | ﹤0.01% |
12,188
-10,386
| -46% | -$54.5K |
|
|
KG
3424
Kestrel Group, Ltd.
KG
$199M
| $64K | ﹤0.01% |
1,569
-1,602
| -51% | -$65.3K |
|
3425
Trump Media & Technology Group
DJT
$4.72B
| $64K | ﹤0.01% |
1,966
+336
| +21% | +$10.9K |
|